Neuroprotective Role of L-Carnitine in Cerebellar Development of Male Albino Rat Offspring Following Tramadol Exposure: A Histopathological Study

Background and Objective: Investigations have highlighted the detrimental neurological outcomes associated with tramadol exposure, yet studies addressing histopathological changes in the cerebellum following prenatal exposure remain limited. Therefore, this study aimed to elucidate alterations in cerebellar architecture induced by tramadol administration during gestation, particularly during the critical period of neuronal differentiation, while evaluating the potential neuroprotective role of L-carnitine. Materials and Methods: A cohort of eight male pups was euthanized at two postnatal time points: one and three weeks after birth. Each age group was divided into four experimental categories: Group I (control); Group II (L-carnitine), where pregnant rats received L-carnitine; Group III (tramadol), where offspring from tramadol-exposed mothers were assessed; Group IV (tramadol + L-carnitine), which included pregnant rats administered both tramadol and L-carnitine. Treatments began on gestational day 7 and continued until day 21. Pups were sacrificed on postnatal days 7 and 21 following treatment, and cerebellar samples were subjected to histological and immunohistochemical analyses to evaluate oxidative stress markers. Data were analyzed using GraphPad Prism v7.01 and expressed as the mean ± SEM; significance (p < 0.05) was assessed using a t-test or one-way ANOVA with the Tukey–Kramer post hoc test. Results: Prenatal tramadol exposure resulted in significant histological alterations in the developing cerebellar cortex of the postnatal offspring. Noteworthy findings included the persistence of the external granular layer, degeneration of Purkinje cells with pericellular halos and vascular congestion, all of which correlated with oxidative stress markers. In contrast, L-carnitine co-administration facilitated a restoration of normative cerebellar architecture. Conclusion: These findings indicate that tramadol exposure during pregnancy elicits substantial degenerative changes in the cerebellar cortex, highlighting L-carnitine co-treatment as a promising strategy to mitigate these tramadol-mediated adverse effects.